Sunitinib in renal-cell carcinoma: expanded indications
- PMID: 19615941
- DOI: 10.1016/S1470-2045(09)70185-8
Sunitinib in renal-cell carcinoma: expanded indications
Comment on
-
Safety and efficacy of sunitinib for metastatic renal-cell carcinoma: an expanded-access trial.Lancet Oncol. 2009 Aug;10(8):757-63. doi: 10.1016/S1470-2045(09)70162-7. Epub 2009 Jul 15. Lancet Oncol. 2009. PMID: 19615940 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
